Life Science Partner is pleased to announce the recruitment of Fred Siebert to Beckman Coulter as Director, Global Clinical Affairs. Beckman Coulter is an innovative diagnostics and life science company that creates the world’s most efficient diagnostic laboratories. It is part of the Danaher group of families. In this new role, Siebert will be responsible […]
Life Science Partner congratulates Max Wallace on his recognition with the CED Life Science Leadership Award for his contributions to the life sciences industry in North Carolina and more broadly. Mr. Wallace currently serves as CEO of Accelerate Brain Cancer Cure (ABC²), a venture philanthropy organization that has helped bring 30 new brain cancer treatments […]
Life Science Partner is pleased to announce the recruitment of Pamela Goldberg to lead the Medical Device Innovation Consortium as President and Chief Executive Officer. Prior to starting her own consulting firm in 2017, Ms. Goldberg served as the CEO of the Massachusetts Technology Collaboration, a public economic development engine designed to foster technological advancements, […]
Life Science Partner is delighted to announce the recruitment of Amanda York, PhD to our recruitment team as Executive Search Associate. Amanda will be responsible for managing our search operations and firm operations, including our research programs and technology platforms. Prior to joining LSP, Amanda earned her PhD in Biochemistry, Cell & Developmental Biology from […]
Life Science Partner is pleased to announce the addition of our newest team member, Josh Lewis, PhD. Josh joins us as Executive Search Associate and is responsible for managing our search operations and firm operations, including our research programs and technology platforms. “Josh brings an additional layer of scientific and technological expertise to the […]
Congratulations to REVA Medical CEO and former Life Science Partner placement Reggie Groves on her feature in this week’s San Diego Business Journal! View the feature here.
DANVERS, Mass., Oct. 08, 2015 (GLOBE NEWSWIRE) — Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Seth Bilazarian, M.D. will be appointed as Vice President of Interventional Cardiology Programs, effective October 8, 2015. “We are excited to welcome Dr. Seth Bilazarian to Abiomed, where he will add a specialized interventional […]
COLUMBIA, Md.–(BUSINESS WIRE)– Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, is pleased to announce the expansion of the management team with the appointment of Adrian Mollo as General Counsel and Dr. Jon Hopper as Chief Medical Officer, both reporting to Lode Debrabandere, […]